DA rats immunized with spinal cord homogenate (SCH) develop experimental autoimmune encephalomyelitis (EAE) which is ameliorated by the treatment of rats with the FFAR2 agonist Cpd1 in the inductive phase of the disease. The gene discussed is FFAR2; the disease is experimental autoimmune encephalomyelitis.